FDA Approval Of Wyeth Menopause Treatment Pristiq Delayed

Wyeth on Thursday said that regulatory approval of its new drug, Pristiq, a nonhormonal treatment for hot flashes and other menopause symptoms, is delayed until at least July to give FDA time to review new data on the drug, the AP/Forbes reports. FDA was scheduled to decide whether to approve Pristiq next week. [click link for full article]
From: www.medicalnewstoday.com